CASEY GILMORE
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant CINCINNATI, OH NPI 1013290782
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant OH ABBVIE INC. All categories
General Payments — all program years on this page
$645.99
- Category: General Payments
- Program years: PY2023–2024
- Record count: 32
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $191.58 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $191.58 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $77.83 | 3 |
| Acerta Pharma LLC | $23.38 | 1 |
| Alkermes, Inc. | $22.81 | 1 |
| Amgen Inc. | $18.48 | 1 |
| Lilly USA, LLC | $17.11 | 1 |
| Axsome Therapeutics, Inc. | $16.56 | 1 |
| Novo Nordisk AS | $15.41 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100265016 | Novo Nordisk Inc | $15.41 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104509806 | AstraZeneca Pharmaceuticals LP | $23.38 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107173858 | ABBVIE INC. | $24.28 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107173860 | ABBVIE INC. | $24.17 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107173862 | ABBVIE INC. | $29.38 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115662502 | Amgen Inc. | $18.48 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120505108 | Alkermes, Inc. | $22.81 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135618797 | Lilly USA, LLC | $17.11 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148345568 | Axsome Therapeutics, Inc. | $16.56 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.